CA1166158A - Agents for treating diseases in circulatory organs - Google Patents

Agents for treating diseases in circulatory organs

Info

Publication number
CA1166158A
CA1166158A CA000379686A CA379686A CA1166158A CA 1166158 A CA1166158 A CA 1166158A CA 000379686 A CA000379686 A CA 000379686A CA 379686 A CA379686 A CA 379686A CA 1166158 A CA1166158 A CA 1166158A
Authority
CA
Canada
Prior art keywords
agent according
piperazine
piperazine compound
salt
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000379686A
Other languages
English (en)
French (fr)
Inventor
Hiroyuki Nagano
Mitiro Takagi
Noboru Kubodera
Isao Matsunaga
Tamotsu Yamazaki
Hiroyuki Nabata
Kazushige Sakai
Shun-Ichi Hata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of CA1166158A publication Critical patent/CA1166158A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000379686A 1980-06-13 1981-06-12 Agents for treating diseases in circulatory organs Expired CA1166158A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP79043/1980 1980-06-13
JP7904380A JPS574921A (en) 1980-06-13 1980-06-13 Remedy for cardiovascular disorder

Publications (1)

Publication Number Publication Date
CA1166158A true CA1166158A (en) 1984-04-24

Family

ID=13678875

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000379686A Expired CA1166158A (en) 1980-06-13 1981-06-12 Agents for treating diseases in circulatory organs

Country Status (9)

Country Link
US (1) US4438115A (enExample)
EP (1) EP0042162B1 (enExample)
JP (1) JPS574921A (enExample)
KR (1) KR850000215B1 (enExample)
AR (1) AR229471A1 (enExample)
AT (1) ATE5372T1 (enExample)
CA (1) CA1166158A (enExample)
DE (1) DE3161490D1 (enExample)
ZA (1) ZA813937B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4397855A (en) * 1981-06-26 1983-08-09 Warner-Lambert Company 4-(Substituted)-α, α-dimethyl-1-piperazine pentanoic acids and derivatives as anti-arteriosclerotic agents and method
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
JPH048416Y2 (enExample) * 1985-10-15 1992-03-03
GB2271930B (en) * 1992-11-03 1996-07-24 Wyeth John & Brother Ltd Pharmaceutical piperazine derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH354084A (fr) * 1955-06-29 1961-05-15 Parke Davis & Co Procédé de préparation de pipérazines
US2922788A (en) 1958-05-26 1960-01-26 Parke Davis & Co Phenylpiperazine compounds and process for producing the same
BE662455A (enExample) * 1964-04-14
FR2326923A1 (fr) * 1975-10-08 1977-05-06 Bouchara Emile Derives du bis(piperazinyl-1)-1,2 ethane
DE2555290A1 (de) * 1975-12-09 1977-06-16 Boehringer Mannheim Gmbh Neue benzopyron-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
AR229471A1 (es) 1983-08-31
KR830006257A (ko) 1983-09-20
EP0042162B1 (en) 1983-11-23
DE3161490D1 (en) 1983-12-29
ATE5372T1 (de) 1983-12-15
KR850000215B1 (ko) 1985-03-06
ZA813937B (en) 1982-07-28
JPS574921A (en) 1982-01-11
JPH0138089B2 (enExample) 1989-08-11
EP0042162A3 (en) 1982-03-10
US4438115A (en) 1984-03-20
EP0042162A2 (en) 1981-12-23

Similar Documents

Publication Publication Date Title
EP0202580B1 (en) 3,4-dihydrobenzopyran derivatives
KR19990007985A (ko) 요실금을 치료하기 위한 α1L-효능제의 용도
RU2162083C2 (ru) Оптически активное производное бензотиепина, способ его получения, активаторы остеогенеза, способ активации остеогенеза, способы лечения
EP0104614B1 (en) Phenylpiperazine derivatives and process for producing the same
CA1295251C (en) Propiophenone derivatives for treatment of pollakiuria (frequency urination)
CA1166158A (en) Agents for treating diseases in circulatory organs
GB2214181A (en) 1,2-ethylene diamine compounds
JP3215338B2 (ja) アミノベンゼンスルホン酸誘導体一水和物及びその製造方法
US3947446A (en) Novel 1-[3-(5,6,7,8-tetrahydronaphth-1-yloxy)-propyl]-piperazine compounds and therapeutic compositions
JP3093419B2 (ja) １，４‐ベンゾチアゼピン誘導体
JPH0154349B2 (enExample)
IE45402B1 (en) Substiduted benzenamines
US3809754A (en) Method of treating diseases of the mucous membrane using compounds of a thiazolidine carboxylic acid and pharmaceutical preparations thereof
US4897423A (en) Dinitrobenzenesulfonamides
US4307097A (en) Method of reducing increased intracranial pressure
EP0105458B1 (en) Alpha-aryl-alpha-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the same
JP3074109B2 (ja) 新規なｎ−ベンジルピペラジン化合物とその製造方法
US4421754A (en) Syndonimine derivatives, process for production thereof, and use thereof
JPH033671B2 (enExample)
US3997667A (en) 1-[3-(Naphth-1-yloxy)-propyl]-piperazine compounds and therapeutic compositions
US4263316A (en) N-(1-Methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulfamoyl benzamide and its derivatives, methods of preparing them and their application to the treatment of troubles of the lower part of the body
JPH02258749A (ja) ポリヒドロキシベンジルオキシプロパノールアミン
US5602123A (en) Therapeutic agent for myocardial ischemic damages or reperfusion
EP0187639A1 (en) Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient
JPS584749A (ja) アミノベンジルアミン誘導体、その製法および薬剤としての用途

Legal Events

Date Code Title Description
MKEX Expiry